ADCT - Wall Street Estimates - ADC Therapeutics SA

Healthcare - Biotechnology - NYSE - CH

$ 1.635

-7.1 %

$ 158 M

Market Cap

-0.68

P/E

Price Target Average

599.00%

Revenue Forecast Estimate

56.91%

EBIT Estimate

6.48%

Net Income Estimate

51.65%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets ADC Therapeutics SA

Wall Street analysts predict an average 1-year price target for ADCT of $11.4 , with forecasts ranging from a low of $7 to a high of $20 .

ADCT Lowest Price Target Wall Street Target

7 USD 328.13%

ADCT Average Price Target Wall Street Target

11.4 USD 599.00%

ADCT Highest Price Target Wall Street Target

20 USD 1123.24%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free